Evidence map›Paper›PMID 41496825›Full record

ArticleRSC advances2026

Low-intensity pulsed ultrasound responsive phase-change nanoparticles loaded with rapamycin for targeted therapy of atherosclerotic plaques.

Dandan Wang, Xiaojing Zhang, Lingpeng Tang, Shengnan Wang, Yifang He, Jiamin Liu, Yanli Wang, Shijie Zhang, Jiangqiong Lai, Guorong Lyu

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dandan WangDepartment of Ultrasound, The Second Affiliated Hospital of Fujian Medical University No. 34 North Zhongshan Road Quanzhou Fujian Province 362000 China lgr_feus@sina.com.
Xiaojing ZhangSecond Clinical Medical College, Fujian Medical University Quanzhou Fujian Province 362000 China.
Lingpeng TangDepartment of Ultrasonography, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital Fuzhou Fujian 350001 China.
Shengnan WangSecond Clinical Medical College, Fujian Medical University Quanzhou Fujian Province 362000 China.
Yifang HeDepartment of Ultrasound, The Second Affiliated Hospital of Fujian Medical University No. 34 North Zhongshan Road Quanzhou Fujian Province 362000 China lgr_feus@sina.com.
Jiamin LiuDepartment of Ultrasound, The Second Affiliated Hospital of Fujian Medical University No. 34 North Zhongshan Road Quanzhou Fujian Province 362000 China lgr_feus@sina.com.
Yanli WangDepartment of Ultrasound, The Second Affiliated Hospital of Fujian Medical University No. 34 North Zhongshan Road Quanzhou Fujian Province 362000 China lgr_feus@sina.com.
Shijie ZhangDepartment of Ultrasound, The Second Affiliated Hospital of Fujian Medical University No. 34 North Zhongshan Road Quanzhou Fujian Province 362000 China lgr_feus@sina.com.
Jiangqiong LaiDepartment of Ultrasound, The 910 Hospital of the Chinese People's Liberation Army Joint Logistic Support Force No. 180 Huayuan Road Quanzhou Fujian Province 362000 China Fj180ljq@sina.com.
Guorong LyuDepartment of Ultrasound, The Second Affiliated Hospital of Fujian Medical University No. 34 North Zhongshan Road Quanzhou Fujian Province 362000 China lgr_feus@sina.com.ORCID https://orcid.org/0000-0003-3123-1138

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis (AS), the primary cause of cardio-cerebrovascular diseases, is characterized by plaques that trigger acute ischemic events. Current therapies face challenges in targeted delivery and efficient local drug release, limiting precise diagnosis and treatment. To address this, we developed an ultrasound-responsive nanosystem for integrated AS diagnosis and therapy. The nanosystem, based on polylactic-

Identifiers

PMID41496825
PMCPMC12766267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.